Feedback / Questions
BBT001 - Bambusa Therapeutics
https://www.dermatologytimes.com/view/bbt001-bispecific-antibody-demonstrates-fast-ad-clearance-and-long-lasting-itch-relief-in-phase-1-trial
Jul 28, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next